Open Orphan plc changes its name to hVIVO plc, learn more here.
Open Orphan plc changes its name to hVIVO plc, learn more here.
Our hLAB’s capabilities for custom assay Development, Validation and tech Transfer to FDA, EMA and ICH guidelines according to GCLP ensuring optimised readouts for assays. Custom assay development extends to a wide range of assay types including viral infectivity assays, anti-viral drugs efficacy assessments, quantitative and qualitative diagnostic real-time RT-PCR, virus microneutralization assays and cell mediated immunity assessments including ELISA assays for the anti-drug antibody analysis, cytokines and chemokines biomarker, ELISpot and Flow Cytometry analysis.
